Arbutus Biopharma, X-Chem And Proteros Announce Arbutus Has ‘identified several molecules that inhibit the SARS-CoV-2 nsp5 main protease’; Arbutues Achieves Worldwide Exclusive License To Identified Molecules

by | Dec 7, 2021 | Extra Jobs | 0 comments

Submit a Comment Cancel reply

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.